Pathfinder Cell Therapy, Inc. (PFND)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 29, 2025
Pathfinder Cell Therapy Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | 2009 - 2008 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '15 Sep 30, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | 2009 - 2008 |
| Cash & Equivalents | 0 | 0.03 | 0.04 | 0.01 | 0.2 | 0.02 | Upgrade
|
| Cash & Short-Term Investments | 0 | 0.03 | 0.04 | 0.01 | 0.2 | 0.02 | Upgrade
|
| Cash Growth | -82.61% | -40.91% | 388.89% | -95.41% | 1206.67% | 16.64% | Upgrade
|
| Receivables | - | - | - | 0.03 | 0.05 | - | Upgrade
|
| Inventory | - | - | - | 0.03 | 0.05 | - | Upgrade
|
| Prepaid Expenses | 0.01 | 0.05 | 0.08 | 0.08 | 0.12 | 0.01 | Upgrade
|
| Total Current Assets | 0.01 | 0.07 | 0.12 | 0.15 | 0.42 | 0.03 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | 0 | - | Upgrade
|
| Other Intangible Assets | 0.03 | 0.03 | 0.04 | 0.21 | 0.23 | 0.16 | Upgrade
|
| Total Assets | 0.04 | 0.11 | 0.16 | 0.36 | 0.64 | 0.19 | Upgrade
|
| Accounts Payable | 0.33 | 0.23 | 0.19 | 0.08 | 0.24 | 0.24 | Upgrade
|
| Accrued Expenses | 1.03 | 0.84 | 0.53 | 0.63 | 0.56 | 0.02 | Upgrade
|
| Short-Term Debt | 5.41 | 4.98 | 3.99 | 2.25 | 0.32 | 0.98 | Upgrade
|
| Other Current Liabilities | - | - | - | 0.02 | 0.01 | 0 | Upgrade
|
| Total Current Liabilities | 6.77 | 6.05 | 4.71 | 2.98 | 1.13 | 1.24 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.23 | 0.23 | 0.08 | Upgrade
|
| Total Liabilities | 6.77 | 6.05 | 4.71 | 3.21 | 1.35 | 1.32 | Upgrade
|
| Common Stock | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.46 | Upgrade
|
| Additional Paid-In Capital | 11.83 | 11.83 | 11.83 | 11.82 | 11.81 | 0.29 | Upgrade
|
| Retained Earnings | -19.23 | -18.44 | -17.05 | -15.34 | -13.19 | -1.87 | Upgrade
|
| Shareholders' Equity | -6.73 | -5.94 | -4.55 | -2.85 | -0.71 | -1.13 | Upgrade
|
| Total Liabilities & Equity | 0.04 | 0.11 | 0.16 | 0.36 | 0.64 | 0.19 | Upgrade
|
| Total Debt | 5.41 | 4.98 | 3.99 | 2.25 | 0.32 | 0.98 | Upgrade
|
| Net Cash (Debt) | -5.41 | -4.96 | -3.95 | -2.25 | -0.12 | -0.97 | Upgrade
|
| Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Filing Date Shares Outstanding | 667.16 | 667.16 | 667.16 | 667.16 | 667.16 | 458 | Upgrade
|
| Total Common Shares Outstanding | 667.16 | 667.16 | 667.16 | 667.16 | 667.16 | 458 | Upgrade
|
| Working Capital | -6.76 | -5.98 | -4.59 | -2.83 | -0.71 | -1.21 | Upgrade
|
| Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Tangible Book Value | -6.76 | -5.98 | -4.59 | -3.06 | -0.93 | -1.29 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.